W. Linert et al., DOPAMINE, 6-HYDROXYDOPAMINE, IRON, AND DIOXYGEN - THEIR MUTUAL INTERACTIONS AND POSSIBLE IMPLICATION IN THE DEVELOPMENT OF PARKINSONS-DISEASE, Biochimica et biophysica acta. Molecular basis of disease, 1316(3), 1996, pp. 160-168
The reactions of dopamine (1-amino-2-(3,4-dihydroxyphenyl)-ethane DA),
5-hydroxydopamine (5-OHDA), and 6-hydroxydopamine (6-OHDA), with mole
cular oxygen - with and without the addition of catalytic amounts of i
ron(III) and other metal ions - have been studied and the implication
of these results with respect to the chemistry involved in the progres
s of Parkinson's disease is discussed, In the presence of O-2 DA react
s spontaneously without the necessity of metal-ion catalysis under the
production of stoichiometric amounts of H2O2, to form initially pink
dopaminochrome, which is not stable and reacts further (without the co
nsumption of dioxygen) to form the insoluble polymeric material known
as 'melanine'. DA reacts with iron(III) yielding an intermediate 1:1 c
omplex, which decomposes releasing Fe(II) and the semiquinone, which r
eacts further under involvement of both Fr(III) and dioxygen. 6-OHDA r
eacts without showing the necessity of such an intermediate, and it is
shown to be able to release iron as Fe(II) from ferritine. On the oth
er hand, it is shown (in vitro) that Fe(II) reacts in a Fenton type re
action with DA and the present H2O2 producing 5-OHDA and especially 6-
OHDA. Based on these mutual interacting reactions a mechanism for the
initiation and progress of Parkinson's disease is suggested. The catal
ytic effects of some other transition-metal ions are presented and an
explanation for the peculiarly toxic effects of manganese(II) is put f
orward. Finally, a possible reason for the effect that nicotine has in
the mitigation of Parkinson's disease is discussed.